Insmed (INSM) Tops Q4 EPS by 20c
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $124.89 -1.11%
Revenue Growth %: +253.1%
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +253.1%
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q4 EPS of ($0.36), $0.20 better than the analyst estimate of ($0.56).
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- BMO Capital Starts American Eagle Outfitters (AEO) at Market Perform
- Freeport-McMoRan shares surge as copper hits record $14,694/ton
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
